Koers Bionano Genomics, Inc.
Aandelen
BNGO
US09075F3055
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7872 USD | -3,51% | -23,57% | -58,35% |
Omzet 2024 * | 38,74 mln. 36,35 mln. | Omzet 2025 * | 50,93 mln. 47,79 mln. | Marktkapitalisatie | 49,95 mln. 46,87 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -87 mln. -81,63 mln. | Nettowinst (verlies) 2025 * | -69 mln. -64,74 mln. | EV/omzet 2024 * | 1,29 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,98 x |
K/w-verhouding 2024 * |
-0,43
x | K/w-verhouding 2025 * |
-0,64
x | Werknemers | 344 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,5% |
Recentste transcriptie over Bionano Genomics, Inc.
1 dag | -10,27% | ||
1 week | -21,56% | ||
Lopende maand | -26,50% | ||
1 maand | -19,23% | ||
3 maanden | -33,67% | ||
6 maanden | -61,34% | ||
Lopend jaar | -56,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 12-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 11-09-23 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 01-07-18 | |
David Barker
CHM | Chairman | 82 | 11-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 01-10-11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 9 M€ | +4,75% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,7872 | -3,51% | 2 357 619 |
17-04-24 | 0,8158 | -4,64% | 1 598 564 |
16-04-24 | 0,8555 | -1,67% | 1 545 198 |
15-04-24 | 0,87 | -11,00% | 3 166 173 |
12-04-24 | 0,9775 | -5,10% | 1 881 942 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,84% | 49,95 mln. | |
+3,10% | 209 mld. | |
+3,48% | 177 mld. | |
+10,91% | 133 mld. | |
+17,56% | 99,89 mld. | |
-2,40% | 61,83 mld. | |
+14,41% | 52,51 mld. | |
-6,21% | 45,54 mld. | |
-3,22% | 39,43 mld. | |
+10,18% | 38,87 mld. |